Muscle relaxants;Muskelrelaxanzien

Anaesthesist

Volumn 46, Issue 1, 1997, Pages 3-13

  Diefenbach, C ^a   Nigrovic, V ^a   Mellinghoff, H ^a   Buzello, W ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

acceleromyography; cisatracurium; electromyography; measurement techniques; mechanomyography; mivacurium; n euromusc ular relaxants; neuromuscular blockade; rocuronium

Indexed keywords

CISATRACURIUM; MIVACURIUM; MUSCLE RELAXANT AGENT; ROCURONIUM; CENTRAL MUSCLE RELAXANT; NEUROMUSCULAR BLOCKING AGENT;

ELECTROMYOGRAPHY; HISTAMINE RELEASE; HUMAN; NEUROMUSCULAR BLOCKING; PHARMACODYNAMICS; REVIEW; ANESTHESIA; METHODOLOGY; PATIENT MONITORING;

ANESTHESIA; HUMANS; MONITORING, INTRAOPERATIVE; MUSCLE RELAXANTS, CENTRAL; NEUROMUSCULAR BLOCKING AGENTS;

EID: 0030638864     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050364     Document Type: Review

References (79)

1. Agoston S (1995) Onset time and evaluation of intubating conditions: rocuronium in perspective. Eur J Anaesthesiol [Suppl 11] 12:31-37 In dieser Übersicht werden am Beispiel von Rocuronium die Konzepte und die Wenigkeit von sog. Intubationsstudien kritisch dargestellt.
2. Alvarez-Gomez JA, Estelles ME, Fabregat J, Perez F, Brugger AJ (1994) Pharmacokinetics and pharmacodynamics of rocuronium bromide in adult patients. Eur J Anaesthesiol 11:53-56 (Suppl.9)
3. Barker P, Langton JA, Wilson IG, Smith G (1992) Movements of the vocal cords on induction of anaesthesia with thiopentone or propofol. Br J Anaesth 69:23-25
4. 95. Die Infusion von Cisatracurium und die Antagonisierbarkeit einer neuromuskulären Restblockade wurden ebenfalls untersucht.
5. Bevan DR, Kahwaji R, Shanks CA, Fragen R, Bikhazi GB, Deepika K, Barry Dyck J, Angst MS (1996) ORG9487 - A new rapid onset muscle relaxant: dose-ranging study in adults. Anesth Analg 82:S27
6. Bikhazi GB, Deepika K, Fonseca J, Restrepo R, Shanmugan N (1996) Cardiovascular effects of ORG 9487 under nitrous oxide barbiturate, fentanyl anesthesia. Anesth Analg 82:S29
7. Booth MG, Marsh B, Bryden FMM, Robertson EN, Baird WLM (1992) A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia. Anaesthesia 47:832-843
8. Botelho SY (1955) Comparison of simultaneously recorded electrical and mechanical activity in myasthenia gravis patients and in partially curarized normal humans. Am J Med 19:693-696
9. Boyd AH, Eastwood NB, Parker CJR, Hunter JM (1995) Pharmacodynamics of the 1R cis-1′R cis isomer of atracurium (51W89) in health and chronic renal failure. Br J Anaesth 74:400-404
10. van den Broek L, Proost JH, Wierda JMKH, Nijoo MD, Hennis PJ (1994) Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block. Eur J Anaesth 11:481-487
11. van den Broek L, Wierda JMKH, Smeulers NJ, Proost JH (1994) Pharmacodynamics and pharmacokinetics of ORG 9487, a new short-acting steroidal neuromuscular blocking agent. Br J Anaesth 73:331-335
12. Brull SJ, Silverman DG (1995) Pulse width, stimulus intensity, electrode placement, and polarity during assessment of neuromuscular block. Anesthesiology 83:702-709
13. Caldwell JE, Heier T, Kitts JB, Lynam DP, Fahey MR, Miller RD (1989) Comparison of the neuromuscular block induced by mivacurium, suxamethonium or atracurium during nitrous oxide-fentanyl anaesthesia. Br J Anaesth 63:393-399
14. Cook DR, Freeman JA, Lai AA, Kang Y, Stiller RL, Aggarwal S, Harrelson JC, Welch RM, Samara B (1992) Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 69:580-585
15. Cooper RA, Maddineni VR, Mirakhur RK, Wierda JMKH, Brady M, Fitzpatrick KTJ (1993) Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (ORG 9426) during isoflurane anaesthesia in patients with and without renal failure. Br J Anaesth 71:222-226
16. Deriaz H, Schmautz E, Vrillon M, Lienhart A (1994) Pharmacodynamics of repeated doses of 51W89 during surgery. Anesthesiology 81:A1092
17. Devlin JC, Head-Rapson AG, Parker CJR, Hunter JM (1993) Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis. Br J Anaesth 71:227-231
18. De Wolf AM, Freeman JA, Scott VL, Tullock W, Smith DA, Kisor DF, Kerls S, Cook DR (1996) Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end stage liver disease undergoing liver transplantation. Br J Anaesth 76:624-628
19. Diefenbach C, Mellinghoff H, Lynch J, Buzello W (1992) Mivacurium: dose-response relationship and administration by repeated injection or infusion. Anesth Analg 74:420-423
20. Diefenbach C, Mellinghoff H, Grand S, Buzello W (1992) Atracurium and vecuronium: repeated bolus injection versus infusion. Anesth Analg 74:519-522
21. Diefenbach C, Abel M, Rump AFE, Grond S, Korb H, Buzello W (1995) Changes in plasma cholinesterase activity and mivacurium neuromuscular block in response to normothermic cardiopulmonary bypass. Anesth Analg 80:1088-1091
22. Eastwood NB, Boyd AH, Parker CJR, Hunter JM (1995) Pharmacokinetics of 1R-cis 1′R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronical renal failure. Br J Anaesth 75:431-435
23. Engbæk J, Østergaard D, Viby-Mogensen J (1989) Double burst stimulation (DBS): a new pattern of nerve stimulation to identify residual block. Br J Anaesth 62:274-278
24. Eriksson LI, Sato M, Severinghaus JW (1993) Effect of a vecuronium-induced partial neuromuscular block on hypoxic ventilatory response. Anesthesiology 78:693-699
25. Eriksson LI (1994) Ventilation and neuromuscular blocking drugs. Acta Anaesthesiol Scand [Suppl 102] 38:11-15
26. Fox MH, Hunt PCW (1995) Prolonged neuromuscular block associated with mivacurium. Br J Anaesth 74:237-238
27. Goudsouzian NG, d'Hollander A, Viby-Mogensen J (1993) Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 77:183-185
28. Harvey AH, Masland RL (1941) A method for study of neuromuscular transmission in man. Johns Hopkins Hosp Bull 68:81-93
29. Head-Rapson AG, Devlin JC, Parker CJR, Hunter JM (1994) Pharmacokinetics of the three isomers of mivacurium and pharmacodynamics of the chiral mixture in hepatic cirrhosis. Br J Anaesth 73:613-618
30. Helbo-Hansen HS, Bang U, Kirkegaard Nielsen H, Skovgaard LT (1991) The accuracy of train-of-four monitoring at varying stimulating currents. Anesthesiology 76:199-203
31. Helbo-Hansen HS, Jensen B, Norreslet J, Kirkegaard Nielsen H, de Haas IM (1995) Response to single twitch or single burst stimulation of the ulnar nerve as predictive guide for intubating conditions. Acta Anaesthesiol Scand 39:498-502
32. Huizinga ACT, Vandenbrom RHG, Wierda JMKH, Hommes FDM, Hennis PJ (1992) Intubation conditions and onset of neuromuscular block of rocuronium (ORG 9426); a comparison with suxamethonium. Acta Anaesthesiol Scand 36:463-468 Rocuronium und Succinylcholin schaffen innerhalb von 60 s vergleichbare Intubationsbedingungen, obwohl die Anschlagszeit von Rocuronium am M. adductor pallicis 2 min langsamer ist als die von Succinylcholin. Etwa 50% der Patienten einer Kontrollgruppe konnten auch ohne Muskelrelaxans mit guten bis sehr guten Bedingungen intubiert werden.
33. Iwasaki H, Igarashi M, Namiki A (1994) A preliminary clinical evaluation of magnetic stimulation of the ulnar nerve for monitoring neuromuscular transmission. Anaesthesia 49:814-816
34. Jensen E, Viby-Mogensen J, Bang U (1988) The Accelograph: a new neuromuscular transmission monitor. Acta Anaesthesiol Scand 32:49-52
35. Kern SE, Johnson JO, Westenskow DR, Orr JA (1994) An effectiveness study of a new piezoelectric sensor for train-of-four measurement. Anesth Analg 78:978-982
36. Khalil M, D'Honneur G, Duvaldestin P, Slavov V, De Hys C, Gomeni R (1994) Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology 80:1241-1247
37. Khuenl-Brady KS, Pühringer F, Koller J, Mitterschiffthaler G (1993) Evaluation of the time course of action of maintenance doses of rocuronium CORG9426) under halothane anaesthesia. Acta Anaesthesiol Scand 37:137-139
38. Khuenl-Brady KS, Pomaroli A, Pühringer F, Mitterschiffthaler G, Koller J (1993) The use of rocuronium (ORG 9426) in patients with chronic renal failure. Anaesthesia 48:873-875
39. Koscielniak-Nielsen ZJ, Horn A, Sztuk F, Eriksen K, Skovgaard LT, Viby Mogensen J (1996) Timing of tracheal intubation: monitoring the orbicularis oculi, the adductor pollicis or use a stopwatch? Eur J Anaesthesiol 13:130-135
40. Krieg N, Mazur L, Booij LHDJ, Crul JF (1980) Intubating conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org NC 45. Acta Anaesthesiol Scand 24:423-425
41. Lambalk LM, de Wit APM, Wierda JMKH, Hennis PJ, Agoston S (1991) Dose-response relationship and time course of action of org9426. A new muscle relaxant of intermediate duration evaluated under various anaesthesia techniques. Anaesthesia 46:907-911
42. Levy JH, Davis GK, Duggan J, Szlam F (1994) Determination of the hemodynamics and histamine release of rocuronium (Org 9426) when administered in increased doses under N20/02-Sufentanil anesthesia. Anesth Analg 78:318-321
43. Lien CA, Schmith VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ (1994) The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 80:1296-1302 In einer pharmakokinetischen Untersuchung werden die Eigenschaften der drei Isomere von Mivacurium dargestellt und Konsequenzen für die Pharmakodynamik von Mivacurium abgeleitet.
44. Lien CA, Belmont MR, Abalos A, Eppich L, Quessy S, Abou-Donia MM, Savarese JJ (1995) The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 82:1131-1138 Die Autoren untersuchten den Einfluß verschiedener Dosierungen von Cisatracurium auf Blutdruck, Herzfrequenz und Plasmahistaminspiegel.
45. Lien CA, Schmith VD, Belmont MR, Abalos A, Kisor DF, Savarese JJ (1996) Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 84:300-308 Diese Arbeit gibt eine umfangreiche Darstellung der pharmakokinetischen Eigenschaften von Cisatracurium.
46. Loan PB, Paxton LD, Mirakhur RK, Connolly FM, McCoy EP (1995) The TOF-guard neuromuscular transmission monitor. Anaesthesia 50:699-702
47. Maddineni VR, Mirakhur RK, McCoy EP, Fee JPH, Clarke RSJ (1993) Neuromuscular effects and intubating conditions following mivacurium: a comparison with suxamethonium. Anaesthesia 48:940-945
48. Magorian T, Flannery KB, Miller RD (1993) Comparison of rocuronium, succinylcholine, and vecuronium for rapid-sequence induction of anesthesia in adult patients. Anesthesiology 79:913-918
49. Magorian T, Wood P, Caldwell J, Fisher D, Segredo V, Szenohradszky J, Sharma M, Gruenke L, Miller R (1995) The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg 80:754-759
50. Mellinghoff H, Diefenbach C, Bischoff A, Grond S, Buzello W (1994) Dose-response relationship of rocuronium bromide during intravenous anaesthesia. Eur J Anaesthesiol 11:S20-S24
51. Meretoja OA, Taivainen T, Wirtavuori K (1995) Pharmacodynamic effects of 51W89, an isomer of atracurium, in children during halothane anaesthesia. Br J Anaesth 74:6-11
52. Mortier E, Rolly G (1989) A contribution to the monitoring of neuromuscular blockade: an evaluation of the Datex Relaxograph. Acta Anaesth Belg 40:123-126
53. Naguib M, Abdulatif M, Al-Ghamdi A, Hamo I, Nouheid R (1993) Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block. Br J Anaesth 71:709-714
54. Naguib M, El-Gammal M, Daoud W, Ammar A, Moukhtar H, Turkistani A (1995) Human plasma cholinesterase for antagonism of prolonged mivacurium-induced neuromuscular blockade. Anesthesiology 82:1288-1292
55. Nigrovic V, Diefenbach C, Mellinghoff H (1991) Ester und Stereoisomere. Anaesthesist
56. Østergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby-Mogensen J (1993) Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase. Acta Anaesthesiol Scand 37:314-318 Die Wirkungsverlängerung von Mivacurium bei hetero- und homozygot atypischer Cholinesterase wird in Dosis-Wirkungsstudien quantifiziert. Die homozygot atypische Cholinesterase führt zu einer nicht kalkulierbaren Zunahme der Wirkdauer von Mivacurium.
57. Østergaard O, Jensen FS, Viby-Mogensen J (1995) Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase. Anesthesiology 82:1295-1298 In zwei Fallberichten wird die rasche Antagonisierbarkeit einer durch Mivacurium induzierten neuromuskulären Blockade bei atypischer Cholinesterase nach intravenöser Gabe von Cholinesterase dargestellt.
58. Oyos TL, Lillehaug SL, Harley PJ, Downs DD, Patel SS, Gergis SD, Sokoll MD (1994) A study of the safety and efficacy of 51W89 in surgical patients during N20/02/opioid, N20/02/ isoflurane, N20/02/enflurane, and N20/02/ propofol anesthesia. Anesthesiology 81:A1117
59. Pollmaecher T, Steiert H, Buzello W (1986) A constant current peripheral nerve stimulator (Neurostim T4). Br J Anaesth 58:1443-1446
60. Quill TJ, Begin M, Glass PSA, Ginsberg B, Gorback MS (1991) Clinical responses to Org9426 during isoflurane anesthesia. Anesth Analg 72:203-206
61. Rupp SM, Castagnoli KP, Fisher DM, Miller RD (1987) Pancuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly adults. Anesthesiology 67:45-49
62. Saitoh Y, Toyooka H, Amaha K (1995) Post-tetanic burst: a new monitoring method for intense neuromuscular block. Br J Anaesth 74:293-295
63. Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RPF, Sunder N, Weakly JN, Wastila WB, El-Sayad HA (1988) The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). Anesthesiology 68:723-732 In dieser Untersuchung wurden die Wirk- und Erholungszeiten verschiedener Einzeldosen von Mivacurium untersucht, ebenso der Zusammenhang zwischen der Aktivität der normalen Plasmacholinesterase und der Wirkdauer von Mivacurium. Die Antagonisierung einer durch Mivacurium induzierten neuromuskulären Blockade mit Neostigmin bringt nur einen geringen Zeitvorteil gegenüber der Spontanerholung.
64. Savarese JJ, Ali HH, Basta SJ, Scott RPF, Embree PB, Wastila WB, Abou-Donia MM, Gelb C (1989) The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia. Anesthesiology 70:386-394 Diese Studie gibt eine umfassende Übersicht über die Wirkungen von Mivacurium auf Blutdruck, Herzfrequenz und Plasmahistaminspiegel. Eine Dosis-Effekt-Relation für histaminbedingte Nebenwirkungen wird erstellt.
65. Savarese JJ (1996) Clinical practice with the new relaxants: fine tunning the medical and economic aspects of relaxation. Anesth Analg [Suppl] 82:114-120 Diese Übersicht beschreibt den praktisch klinischen Umgang (Indikationen und Dosierungen) mit den neuen Muskelrelaxanzien Rocuronium, Mivacurium und Cisatracurium.
66. Shanks CA, Fragen RJ, Ling D (1993) Continuous intravenous infusion of rocuronium (org 9426) in patients receiving balanced, enflurane, or isoflurane anesthesia. Anesthesiology 78:649-651
67. Striebel HW, Hölzl M, Rieger A, Brummer G (1995) Endotracheale Intubation unter Propofol und Fentanyl. Anaesthesist 44:809-817 Diese Untersuchung stellt die Bedeutung des Einleitungsregimes für die Intubationsbedingungen heraus und zeigt, daß gute Intubationsbedingungen auch ohne neuromuskuläre Blockade erzielbar sind.
68. Viby-Mogensen J (1982) Clinical assessment of neuromuscular transmission. Br J Anaesth 54:209-223 In einer Übersicht werden die Stimulationsmuster und Meßverfahren zur Überwachung einer neuromuskulären Blockade anschaulich dargestellt.
69. Viby-Mogensen J, Jensen E, Werner M, Kirkegaard-Nielsen H (1988) Measurement of acceleration: a new method of monitoring neuromuscular function. Acta Anaesthesiol Scand 32:45-48
70. Viby-Mogensen J (1995) Mivacurium block in patients with abnormal plasma cholinesterase. Acta Anaesthesiol Scand 39:1001-1002 In diesem Editorial sind alle denkbaren Ursachen einer verlängerten Wirkdauer von Mivacurium und deren therapeutische Konsequenzen zusammengestellt.
71. Viby-Mogensen J, Engbaek J, Eriksson LI, Gramstad L, Jensen E, Jensen FS, Koscielniak-Nielsen Z, Skovgaard LT, Ostergaard D (1996) Good clinical research practice (GRCP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 40:59-74 Diese Arbeit enthält eine ausführliche Darstellung der Richtlinien für pharmakodynamische Untersuchungen mit Muskelrelaxanzien, wie sie auf der Konsensuskonferenz 1994 in Kopenhagen beschlossen wurden.
72. Ward S, Boheimer N, Weatherley BC, Simmonds RJ, Dopson TA (1987) Pharmacokinetics of atracurium and its metabolites in patients with normal renal function and in patients in renal failure. Br J Anaesth 59:697-706
73. Wastila WB, Maehr RB (1993) The pharmacological profile of 51W89, the R, Cis-R', cis isomer of atracurium cats. Anesthesiology 79:A946
74. Wastila WB, Maehr RB, LaMunion GL, Belmont MR, Savarese JJ (1996) Preclinical pharmacology of cisatracurium besylate. Curr Opin Anaesth [Suppl 1]9:S2-S8
75. Welch RM, Brown A, Ravitch J, Dahl R (1995) The in vitro degradation of cisatracurium, the R, cis-R'-Isomer of atracurium, in human and rat plasma. Clin Pharmacol Ther 58:132-142
76. Wierda JMKH, Kleef UW, Lambalk LM, Kloppenburg WD, Agoston S (1991) The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl. Can J Anaesth 38:430-435
77. Wierda JMKH, van den Broek L, Proost JH, Verbaan BW, Hennis PJ (1993) Time course of action and endotracheal intubating conditions of org 9487, a new short-acting steroidal muscle relaxant; a comparison with succinylcholine. Anesth Analg 77:574-578
78. Wierda JMKH, Hommes FDM, Nap HJA, van den Boeck L (1995) Time course of action and intubating conditions following vecuronium, rocuronium and mivacurium. Anaesthesia 50:393-396
79. Wright PMC, Caldwell JE, Miller RD (1994) Onset and duration of rocuronium and succinylcholine at the adductor pollicis and laryngeal adductor muscles in anesthetized humans. Anesthesiology 81:1110-1115